About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Dr. Lal Pathlabs Ltd.
Industry :
Hospital & Healthcare Services
BSE Code
539524
ISIN Demat
INE600L01024
Book Value
248.02
NSE Code
LALPATHLAB
Dividend Yield %
0.86
Market Cap
233566.12
P/E
46.97
EPS
59.36
Face Value
10
BSE
NSE
01-Jul-2025 10:24
BSE
NSE
NSE F & O
01-Jul-2025 10:19
BSE
NSE
NSE F & O
Last Price
2788.00
Net Change
-6.7
% Change
-0.24%
Prev.Close
2794.70
Open
2794.95
High
2809.00
Low
2775.00
Volume
446
Last Price
2789.10
Net Change
-7.2
% Change
-0.26%
Prev.Close
2796.30
Open
2818.80
High
2818.80
Low
2773.70
Volume
117877
Value
1243448
Best Buy
2790.10
Best Sell
2792.95
Best Quantity
2
Sell Quantity
8
Today's Range
2809.00
52-Week High
3645.00
52-Week Low
2295.10
Value
328770740.7
Best Buy
2786.70
Best Sell
2787.90
Best Quantity
5
Sell Quantity
3
Today's Range
2818.80
52-Week High
3653.95
52-Week Low
2293.55
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
2
Price
2790.10
Quantity
8
Price
2792.95
Best Bid
Best Offer
Quantity
5
Price
2786.70
Quantity
3
Price
2787.90
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
06-Aug-19
12-Aug-19
Dividend
60 %
06-Jun-25
Company News
25-06-2025
Dr. Lal PathLabs expands ...
25-06-2025
Dr. Lal PathLabs informs ...
25-06-2025
Dr. Lal PathLabs surges o...
04-06-2025
Dr. Lal PathLabs informs ...
04-06-2025
Dr. Lal PathLabs informs ...
19-05-2025
Dr. Lal PathLabs informs ...
08-05-2025
Dr. Lal PathLabs informs ...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
